| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |